Wegovy maker Novo Nordisk has hired the start-up Deep Apple Therapeutics to develop small molecules as its next weight-loss ...

Camurus licensed its FluidCrystal drug delivery tech to Eli Lilly for global development of long-acting incretin therapies ...

Novo Nordisk is rapidly ceding market share to Eli Lilly. And the paradigm shift is showing up in Novo Nordisk stock.

SANTA CLARA, Calif.--(BUSINESS WIRE)--Exo Imaging, a leading innovator in ultrasound medical imaging technology, today announced a strategic collaboration with Samsung Medison to co-develop ...

Eli Lilly and Co. announced plans on Tuesday to acquire private biotechnology company San Francisco-based SiteOne Therapeutics Inc. in a deal worth up to $1 billion. SiteOne, founded in 2010 ...

At the same time, pharmaceutical companies leading the GLP-1 charge — particularly Eli Lilly (LLY) — are surging. In this post, I’ll break down what’s happening in the alcohol industry, the science ...

Pharmaceutical company Eli Lilly has announced plans to acquire private biotech company SiteOne in a deal worth up to $1 billion. This move has been done to expand the company’s neuroscience ...

This past semester, that kind of collaboration took on a new meaning when I connected with Isha Singh, a master’s student in computer science, through a course that turned into one of the most pivotal ...

The company's lead drug recently completed an early-stage clinical trial, aiming to stop pain without setting off addiction. Thursday, June 12, 2025 Best Places to Work in the Bay Area Awards In ...

Congratulations to the entire SiteOne family on acquisition by Eli Lilly announced this morning. It was an honor to serve as Exec Chair. Thanks to John Mulcahy, CEO, John Hunter, CSO, Diana Chung ...

Eli Lilly: "I just think this is a decent level to start a position if you don't have any [buy, buy, buy!]." Stream Connecticut News for free, 24/7, wherever you are. Navitas: "That one's done ...